I agree that this site is using cookies. You can find further informations here.
X
Todenhöfer, Tilman
196  results:
Search for persons X
?
1

Pembrolizumab plus Abiraterone Acetate and Prednisone in Pa..:

Yu, Evan Y. ; Ferrario, Cristiano ; Linch, Mark D....
European Urology Oncology.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Pembrolizumab and Enzalutamide in Patients with Abiraterone..:

Yu, Evan Y. ; Berry, William R. ; Gurney, Howard...
European Urology Oncology.  7 (2024)  3 - p. 509-518 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Derazantinib alone and with atezolizumab in metastatic urot..:

Necchi, Andrea ; Ramlau, Rodryg ; Falcón González, Alejandro...
JNCI Cancer Spectrum.  8 (2024)  3 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
4

Interleukin-1β/Interleukin (IL)-1-Receptor-Antagonist (IL1-..:

Vukovic, Marko ; Chamlati, Jorge M. ; Hennenlotter, Jörg...
International Journal of Molecular Sciences.  25 (2024)  4 - p. 2447 , 2024
Link: https://doi.org/10.3390/..
 
?
5

Simulation of the effects of molecular urine markers in fol..:

Benderska-Söder, Natalya ; Ecke, Thorsten ; Kleinlein, Lisa...
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  8 - p. 229-235 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Corrigendum to "Pembrolizumab plus Olaparib in Patients wit..:

Yu, Evan Y. ; Piulats, Josep M. ; Gravis, Gwenaelle...
European Urology.  83 (2023)  3 - p. e87 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Bladder preservation after neoadjuvant therapy – 2021 IBCN ..:

Hensley, Patrick J. ; Seiler, Roland ; Herr, Harry...
Urologic Oncology: Seminars and Original Investigations.  41 (2023)  7 - p. 307-312 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Pembrolizumab plus Olaparib in Patients with Metastatic Cas..:

Yu, Evan Y. ; Piulats, Josep M. ; Gravis, Gwenaelle...
European Urology.  83 (2023)  1 - p. 15-26 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Triptorelinembonat besser alle sechs statt alle drei Monate..:

Rexer, Heidrun ; Todenhöfer, Tilman ; Graefen, Markus
Uro-News.  27 (2023)  4 - p. 64-65 , 2023
Link: https://doi.org/10.1007/..
 
?
10

Adjuvante Phase-III-Studie für Patienten mit lokal fortgesc..:

Rexer, Heidrun ; Todenhöfer, Tilman ; Graefen, Markus
Forum.  38 (2023)  4 - p. 336-337 , 2023
Link: https://doi.org/10.1007/..
 
?
11

Differential Expression and Clinical Relevance of C-X-C Mot..:

Maas, Moritz ; Kurcz, Aymone ; Hennenlotter, Jörg...
International Journal of Molecular Sciences.  24 (2023)  6 - p. 5227 , 2023
Link: https://doi.org/10.3390/..
 
?
12

Discriminative capacity of guideline recommendations in the..:

Kuckuck, Eva Charlotte ; Hennenlotter, Jörg ; Todenhöfer, Tilman...
Urologic Oncology: Seminars and Original Investigations.  41 (2023)  5 - p. 254.e1-254.e8 , 2023
Link: https://doi.org/10.1016/..
 
?
13

25 years International Bladder Cancer Network (IBCN): The p..:

Dyrskjøt, Lars ; Vlahou, Antonia ; Black, Peter C....
Urologic Oncology: Seminars and Original Investigations.  41 (2023)  7 - p. 302-306 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Urine biomarkers in bladder cancer — current status and fut..:

Maas, Moritz ; Todenhöfer, Tilman ; Black, Peter C.
Nature Reviews Urology.  20 (2023)  10 - p. 597-614 , 2023
Link: https://doi.org/10.1038/..
 
?
15

IBCN Seminar Series 2021: Circulating tumor DNA in bladder ..:

Christensen, Emil ; Wyatt, Alexander W. ; Galsky, Matthew D....
Urologic Oncology: Seminars and Original Investigations.  41 (2023)  7 - p. 318-322 , 2023
Link: https://doi.org/10.1016/..
 
1-15